Drugs as risk factors of food anaphylaxis in adults;Facteurs de risque d'anaphylaxie alimentaire sévère Rôle confirmé de certaines classes de médicaments

Medecine/Sciences

Volumn 26, Issue 8-9, 2010, Pages 719-723

  Moneret Vautrin, Denise Anne ^a  

^a UNIVERSITY HOSPITAL OF NANCY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77957312634     PISSN: 07670974     EISSN: None     Source Type: Journal    
DOI: 10.1051/medsci/2010268-9719     Document Type: Review

References (44)

1. Johansson S, BieberT, Dahl R, et al. Revised nomenclature for allergy for global use: report of the romenclature review committee of the World Allergy Organization, October 2001. J Allergy Clin Immunol 2004; 113: 832-6.
2. Moneret-Vautrin DA, Morisset M, Flabbee J, et al. Epidemiology of life-threatening and lethal anaphylaxis: a review. Allergy 2005; 60: 443-51. (Pubitemid 40332968)
3. Gupta R, Sheikh A, Strachan D, Anderson HR. Time trends in allergic disorders in the UK. Thorax 2006; 62: 91-6.
4. Poulos LM, Waters AM, Corell P, et al. Trends in hospitalizations for anaphylaxis, angioedema, and urticaria in Australia, 1993-1994 to 2004-2005. J Allergy Clin Immunol 2007; 120: 878-84.
5. Kanny G, Moneret-Vautrin DA, Flabbee J, et al. Population study of food allergy in France. J Allergy Clin Immunol 2001; 108: 133-40. (Pubitemid 32662245)
6. Simon MR, Mulla ZD. A population-based epidemiologic analysis of deaths from anaphylaxis in Florida. Allergy 2008; 63: 1077-83.
7. Pumphrey R. Lessons for management of anaphylaxis from a study of fatal reactions. Clin Exp Allergy 2000; 30: 1144-50. (Pubitemid 30619768)
8. Greenberger PA, Rotskoff BD, Lifschultz B. Fatal anaphylaxis: postmortem findings and associated comorbid diseases. Ann Allergy Asthma Immunol 2007; 98: 252-7. (Pubitemid 46417570)
9. Brokow K, Jofer C, Behrendt H, Ring J. Anaphylaxis in patients with mastocytosis: a study on history, clinical features and risk factors in 120 patients. Allergy 2008; 63: 226-32.
10. Mueller UR. Cardiovascular disease and anaphylaxis. Curr Opin Allergy Clin Immunol 2007; 7: 337-41.
11. Liew WK, Williamson E, Tang ML Anaphylaxis fatalities and admissions in Australia. J Allergy Clin Immunol 2009; 123: 434-42.
12. Burks AW. Factoring PAF in anaphylaxis. N Engl J Med 2008; 358: 79-81.
13. Cowburn AS, Slodek K, Soja J, et al. Overexpression of leukotriene c4 synthase in bronchial biopsies from patients with aspirin-intolerant asthma. J Clin Invest 1998 ; 10: 834-46. (Pubitemid 28096081)
14. Drouet C, Desormeaux A, Robillard J, et al. Metallopeptidase activities in hereditary angioedema: effect of androgen prophylaxis on plasma aminopeptidase P. J Allergy Clin Immunol 2007; 121: 429-3.
15. Vadas P, Gold M, Perelman B, et al. Platelet-activating factor, PAF acetylhydrolase, and severe anaphylaxis. N Engl J Med 2008; 3: 28-35.
16. Dzau VJ. Vascular renin-angiotensin system and vascular protection. J Cardiovasc Pharmacol 1993; 22: S1-9.
17. Toogood JH. Risk of anaphylaxis in patients receiving beta-blocker drugs. J Allergy Clin Immunol 1988; 81: 1-5.
18. Laxenaire MC, Torreas J, Moneret-Vautrin DA. Fatal anaphylactic shock in a patient treated with betablockers. Ann Fr Anesth Reanim 1984; 3: 453-5.
19. Moneret-Vautrin DA, Kanny G, Faller J, et al. Severe anaphylactic shock with heart arrest caused by coffee and gum arabic, potentiated by beta-blocking eyedrops. Rev Med Interne 1993; 14: 107-11.
20. Dohi M, Suko M, Sjiyama H, et al. Three cases of food-dependent exercise-induced anaphylaxis in which aspirin intake exacerbated anaphylactic symptoms. Aerugi 1990; 39: 1598-604.
21. Horada S, Horikawa T, Ashida M, et al. Aspirin enhances the induction of type i allergic symptoms when combined with food and exercise in patients with food-dependent exercise-induced anaphylaxis. Br J Dermatol 2001; 145: 336-9. (Pubitemid 32955367)
22. Moneret-Vautrin DA, Latarche C. Médicaments facteurs de risque de sévérité de l'anaphylaxie alimentaire de l'adulte. Étude cas-contrôle. Bull Acad Natl Med 2009; 193: 51-63.
23. Inagaki N, Miura T, Nagai H, Koda A. Antiallergic mechanisms of beta-adrenergic stimulants in rats. Life Sci 1992; 51: 201-5.
24. Boudin B. L'enzyme de conversion de l'angiotensine 1 (ECA) dans le diagnostic de la sarcoïdose. Pathol Biol 2005; 53: 183-8.
25. Adam A, Desormeaux A, Moreau ME. Phytopathology of the acute adverse effects of angiotensinconvertmg-enzyme inhibitors. Bull Acad Natl Med 2007; 191: 1433-44.
26. Gabb GM, Ryan P, Wing LM, Hutchinson KA. Epidemiological study of angioedema and ACE inhibitors. Aust NZ J Med 1996; 26: 777-82. (Pubitemid 27072782)
27. Summers CW, Pumphrey RS, Woods CN, et al. Factors predicting anaphylaxis to peanuts and tree nuts in patients referred to a specialist center. J Allergy Clin Immunol 2008 ; 121: 632-8.
28. Moneret-Vautrin DA, Bilain H, Kanny G, Bloch y. Anaphylaxis to walnuts and pine nuts induced by ACE. Allergy 1998; 53: 1233-4. (Pubitemid 29038007)
29. Hermann K, Von Tschirschnitz M, Ebner von Eschenbach C, Ring J. Histamine, tryptase, norepinephrine, angiotensinogen, angiotensin-convertmg enzyme, angiotensin i and ii in plasma of patients with hymenoptera venom anaphylaxis. Int Arch Allergy Immunol 1994; 104: 379-84.
30. Hermann K, Ring J. The renin-angiotensin system in patients with repeated anaphylactic reactions during hymenoptera venom hyposensitization and sting challenge. Int Arch Allergy Immunol 1997; 112: 251-6. (Pubitemid 27091177)
31. Fujii H, Kambe N, Fujisawa A, et al. Food-dependent exercise-induced anaphylaxis induced by low dose aspirin therapy. Allergol Int 2008; 57: 97-8. (Pubitemid 351413251)
32. Rabassa AA, Goodgame R, Sutton FM, et al. Effects of aspirin and helicobacter pylori on the gastroduodenal mucosal permeability to sucrose. Gut 1996; 39: 159-63. (Pubitemid 26275988)
33. Matsuo H, Morimoto K, Akaki T, et al. Exercise and aspirin increase levels of circulating gliadin peptides in patients with wheat-dependent exercise-induced anaphylaxis. Clin Exp Allergy 2005; 35: 461-6. (Pubitemid 40577238)
34. Smecuol E, Bai JC, Sugai E, et al. Acute gastrointestinal permeability responses to different nonsteroidal anti-inflammatory drugs. Gut 2001; 4: 650-5.
35. Aihara M, Miyazawa M, Osuna H, et al. Food-dependent exercise-induced anaphylaxis: influence of concurrent aspirin administration on skin testing and provocation. Br J Dermatol 2002; 146: 466-72. (Pubitemid 34603819)
36. Yano H, Kato Y, Matsuo T. Acute exercise induces gastrointestinal leakage of allergen in lysozymesensitized mice, Eur Appl Physiol 2002; 87: 358-64. (Pubitemid 36075274)
37. Sudheer PS, Hall JE, Donev R, et al. Nicotinic acetylcholine receptors on basophils and mast cells. Anaesthesia 2006; 61: 1170-4. (Pubitemid 44697856)
38. Scholl I, Untersmayr E, Bakos N, et al. Antiulcer drugs promote oral sensitization and hypersensitivity to hazelnut allergens in balb/c mice and humans. Am J Clin Nutr 2005; 81: 154-60. (Pubitemid 43073389)
39. Sattler J, Hesterberg R, Lorentz W, et al. Inhibition of human and canine diamine oxidase by drugs used in an intensive care unit: relevance for clinical side effects? Agents Actions 1985; 16: 91-4. (Pubitemid 15116664)
40. Korhonen H, Fisslthaler B, Moers A, et al. Anaphylactic shock depends on endothelial gq/g11 J Exp Med 2009; 206: 411-20.
41. Rueff F, Przybilla B, Bilo MB, et al. Predictors of severe systemic anaphylactic reactions in patients with Hymenoptera venom allergy: importance of baseline serum tryptase - a study of the European Academy of Allergology and Clinical Immunology interest group on insect venom hypersensitivity J Allergy Clin Immunol 2009; 124: 1047-54.
42. Javeed N, Javeed H, Javeed S, et al. Refractory anaphylactoid shock potentiated by beta-blockers. Cathet Cardiovasc Diagn 1996; 3: 383-4. (Pubitemid 26423985)
43. Tenbrook JA, Wolf MP, Hoffman SN, et al. Should beta-blockers be given to patients with heart disease and peanut-induced anaphylaxis? A decision analysis. J Allergy Clin Immunol 2004; 113: 977-82.
44. Moneret-Vautrin DA. Le risque allergique et le rôle du Réseau d'allergovigilance Bull Acad Natl Med 2007; 191: 807-14.